383 related articles for article (PubMed ID: 36110953)
21. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.
Li F; Ge D; Sun SL
BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754
[TBL] [Abstract][Full Text] [Related]
22. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
Tian Q; Zhou Y; Zhu L; Gao H; Yang J
Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361
[No Abstract] [Full Text] [Related]
23. A 9‑gene expression signature to predict stage development in resectable stomach adenocarcinoma.
Liu Z; Liu H; Wang Y; Li Z
BMC Gastroenterol; 2022 Oct; 22(1):435. PubMed ID: 36241983
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma.
Wang Y; Xu J; Fang Y; Gu J; Zhao F; Tang Y; Xu R; Zhang B; Wu J; Fang Z; Li Y
Front Immunol; 2022; 13():950001. PubMed ID: 36091041
[TBL] [Abstract][Full Text] [Related]
25. A novel immunogenomic signature to predict prognosis and reveal immune infiltration characteristics in pancreatic ductal adenocarcinoma.
Li A; Ye B; Lin F; Wang Y; Miao X; Jiang Y
Precis Clin Med; 2022 Jun; 5(2):pbac010. PubMed ID: 35694712
[TBL] [Abstract][Full Text] [Related]
26. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
27. Identification of a four-gene panel predicting overall survival for lung adenocarcinoma.
Li C; Long Q; Zhang D; Li J; Zhang X
BMC Cancer; 2020 Dec; 20(1):1198. PubMed ID: 33287749
[TBL] [Abstract][Full Text] [Related]
28. A novel prognostic model related to oxidative stress for treatment prediction in lung adenocarcinoma.
Peng H; Li X; Luan Y; Wang C; Wang W
Front Oncol; 2023; 13():1078697. PubMed ID: 36798829
[TBL] [Abstract][Full Text] [Related]
29. A Robust Seven-Gene Signature Associated With Tumor Microenvironment to Predict Survival Outcomes of Patients With Stage III-IV Lung Adenocarcinoma.
Zhao H; Zhang X; Guo L; Shi S; Lu C
Front Genet; 2021; 12():684281. PubMed ID: 34552612
[TBL] [Abstract][Full Text] [Related]
30. Identification and Validation of a Novel Immune-Related Four-lncRNA Signature for Lung Adenocarcinoma.
Wang J; Yin X; Zhang YQ; Ji X
Front Genet; 2021; 12():639254. PubMed ID: 33708243
[TBL] [Abstract][Full Text] [Related]
31. Identification of an Endoplasmic Reticulum Stress-Related Gene Signature to Evaluate the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma.
Song D; Zhou Z; Zhang D; Wu J; Hao Q; Zhao L; Ren H; Zhang B
Front Genet; 2022; 13():850200. PubMed ID: 35711939
[TBL] [Abstract][Full Text] [Related]
32. Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma.
Liu L; Xu S; Huang L; He J; Liu G; Ma S; Weng Y; Huang S
Transl Cancer Res; 2021 Jun; 10(6):2859-2872. PubMed ID: 35116596
[TBL] [Abstract][Full Text] [Related]
33. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
Zuo S; Wei M; Wang S; Dong J; Wei J
Front Immunol; 2020; 11():1218. PubMed ID: 32714316
[No Abstract] [Full Text] [Related]
34. Comprehensive analysis identifies DNA damage repair-related gene HCLS1 associated with good prognosis in lung adenocarcinoma.
Liu T; Hu A; Chen H; Li Y; Wang Y; Guo Y; Liu T; Zhou J; Li D; Chen Q
Transl Cancer Res; 2023 Oct; 12(10):2613-2628. PubMed ID: 37969376
[TBL] [Abstract][Full Text] [Related]
35. Identification of Key Genes Related to CD8+ T-Cell Infiltration as Prognostic Biomarkers for Lung Adenocarcinoma.
Du M; Liang Y; Liu Z; Li X; Liang M; Zhou B; Gao Y
Front Oncol; 2021; 11():693353. PubMed ID: 34650911
[TBL] [Abstract][Full Text] [Related]
36. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Yang KS; Xu CQ; Lv J
Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
38. A four-gene prognostic signature for predicting the overall survival of patients with lung adenocarcinoma.
Liu L; He H; Peng Y; Yang Z; Gao S
PeerJ; 2021; 9():e11911. PubMed ID: 34631307
[TBL] [Abstract][Full Text] [Related]
39. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
40. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
